Study guide
5.3 Labeling Requirements and Rejection Criteria
ASCP Medical Laboratory Assistant MLA
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the ASCP MLA Exam 1.2 Eligibility Routes and Study Plan
2 Chapter 2: Orders, Identification & Communication
2.1 Review, Clarification, and Verification of Test Orders 2.2 Patient Identification 2.3 Patient Communication
3 Chapter 3: Collection Procedures
3.1 Patient Assessment and Preparation 3.2 Site Selection 3.3 Tubes, Anticoagulants, and Order of Draw 3.4 Specimen Types for Common Tests
4 Chapter 4: Special Collections, Reactions & Handling
4.1 Special Collection Procedures 4.2 Adverse Collection Reactions 4.3 Specimen Labeling and Immediate Handling
5 Chapter 5: Specimen Acceptability Assessment
5.1 Correct Specimen Type for the Test 5.2 Specimen Quality Assessment 5.3 Labeling Requirements and Rejection Criteria 5.4 Time, Temperature, and Light Handling
6 Chapter 6: Add-on Requests & Special Specimen Types
6.1 Specimen Suitability for Add-on Requests 6.2 Special Specimen Types
7 Chapter 7: Prioritization, Distribution & Transport
7.1 Department Distribution and Prioritization 7.2 Pneumatic Tube System 7.3 External Packaging and Shipment
8 Chapter 8: Specimen Processing Techniques
8.1 Centrifugation 8.2 Aliquoting 8.3 Non-Blood Specimen Processing 8.4 Microbiology Setup and Plating
9 Chapter 9: Slide Preparation & Specimen Storage
9.1 Slide Preparation 9.2 Specimen Storage (Pre- and Post-Testing)
10 Chapter 10: Reagents, Instrumentation & Quality Control
10.1 Reagents, Standards, and Controls 10.2 Analytical Instrumentation 10.3 Quality Control
11 Chapter 11: Critical Values, Results & Inventory
11.1 Critical Value Notification and Documentation 11.2 Result Retrieval and Review 11.3 Inventory Management
12 Chapter 12: Waived & Point-of-Care Testing
12.1 Waived and POC Instrument Operation 12.2 Waived/POC QC, Result Evaluation & Reporting
13 Chapter 13: Laboratory Regulations, Chemical & Fire Safety
13.1 Laboratory Regulations 13.2 Chemical Safety 13.3 Fire Safety
14 Chapter 14: Infection Control & Waste Disposal
14.1 Standard Precautions, PPE & Hand Hygiene 14.2 Biological Safety Cabinets, Sharps & Exposure Control 14.3 Biological and Hazardous Waste Disposal
15 Chapter 15: Equipment, Ethics, LIS & Quality Assurance
15.1 Laboratory Equipment Maintenance 15.2 Professionalism, Ethics & HIPAA 15.3 Laboratory Information System (LIS) Functions 15.4 Quality Assurance and Improvement
5.3 Labeling Requirements and Rejection Criteria
Key Takeaways Explain This Topic AI
Unlabeled or mislabeled specimens are major patient-safety events—reject and recollect; never guess the patient
Labels must match the requisition/order: two identifiers minimum, plus collection data required by policy (date/time/collector)
Opened, expired, or compromised tubes fail integrity checks even if labels look perfect
Re-labeling is allowed only through a policy-approved process with verification—never informal handwritten 'fixes' at the bench
Last updated: August 2026
5.3 Labeling Requirements and Rejection Criteria
Quick Answer: Specimens must be labeled at collection with at least two patient identifiers that match the order. Unlabeled or mislabeled samples are rejected and recollected. Do not re-label from memory or from a nearby requisition. Opened or expired tubes also fail acceptance. When identity is uncertain, patient safety beats convenience every time.
Wrong-blood-in-tube (WBIT) errors drive transfusion disasters, incorrect chemotherapy decisions, and false diagnoses. The MLA is a control point: accessioning and processing staff must enforce labeling rules without exceptions based on “the nurse said it’s fine.”
Minimum Labeling Requirements
Facility policies align with accreditation and CLSI-oriented practice. Expect labels to include:
- Element Why required
- Patient full name Primary identity
- Second identifier (MRN, DOB, unique ID) Prevents same-name mix-ups
- Date and time of collection Stability, timed tests, audit trail
- Collector ID/initials Accountability, follow-up
- Specimen type/source when not obvious Urine vs fluid vs blood; left/right; catheter vs void
Blood bank specimens often require stricter rules (e.g., unique BB armband number, witnessed draw). Follow the blood bank SOP exactly—general chemistry flexibility does not apply.
Labels should be placed so barcodes scan, tubes still fit centrifuges and analyzers, and information is not written only on the bag or requisition. A requisition is not a label for an unlabeled tube.
Unlabeled Specimens
An unlabeled tube, cup, or bottle has no acceptable identity . Standard action:
Do not process, centrifuge for testing, or aliquot into labeled secondary tubes as a workaround.
Reject per SOP.
Notify the collecting location for recollection.
Document and dispose of biohazard material according to policy (some labs retain briefly under quarantine for risk management—follow written procedure, not verbal shortcuts).
Rare exceptions (e.g., irreplaceable CSF drawn in OR) require supervisor/pathologist management with documented limited testing and clinical acknowledgment—not MLA freehand labeling.
Mislabeled Specimens and Mismatched Requisitions
Mislabeled means the label identity does not match the patient who was actually drawn, or two conflicting identities appear (tube vs requisition vs LIS order).
Examples:
Tube says Patient A; order/requisition says Patient B.
Name matches but MRN/DOB do not.
Two patient labels on one bag with one tube.
Handwritten name over a different printed label.
Correct response: treat as identity failure → reject and recollect . Staff must not :
Call the floor and re-label based on “we’re sure.”
Cross out one name and write another.
Assume the LIS order is right and the tube is wrong (or vice versa) without a formal process.
Problem resolution may include occurrence reporting, QAPI review, and education of collectors—but the specimen itself remains unsafe for resulting.
Incomplete Labels
Incomplete is not always the same as unlabeled. Policies distinguish:
- Problem Typical handling
- Missing second identifier Often reject (especially blood bank)
Missing collection time on timed/critical stability tests Reject or require collector confirmation per SOP—many labs reject
Missing collector ID May allow correction via documented collector attestation if identity is solid— policy-specific
Smeared barcode but readable backup identifiers May re-print label under controlled process after dual verification
When in doubt, escalate to lead/supervisor rather than inventing a fix. The exam emphasis is: incomplete critical identity elements = do not guess .
- Integrity Failures Beyond Writing: Opened and Expired Tubes
- Opened tubes / missing stoppers
An opened primary tube may be:
- Contaminated
- Evaporated (concentrated analytes)
- Exposed to air (blood gas and some analyte changes)
- Tampered with in chain-of-custody contexts
Reject opened diagnostic tubes when integrity cannot be assured. Do not recap and pretend the closed system was maintained.
Expired tubes
Evacuated tubes past expiration can have:
- Weak vacuum → short draws / QNS
- Degraded additive → microclots, wrong ratios, poor gel performance
Do not use expired tubes for collection; if received, follow reject/recollect rules. Inventory FIFO (first-in, first-out) prevents this upstream.
- Other integrity rejects
- Cracked tubes, leaking specimens
- Gross external contamination that risks staff safety and label readability
- Specimens transported in food containers or unapproved vessels
- Rejection Versus Problem Resolution
Not every paperwork glitch requires destroying a hard-to-replace sample, but identity uncertainty always prioritizes rejection .
- Situation Lean toward
- Unlabeled or conflicting patient IDs Reject / recollect
- Wrong specimen type or clotted EDTA for CBC Reject / recollect
- Minor LIS comment typo with perfect dual ID match Correct via defined registration process
- Missing non-critical comment field Problem resolve per SOP
- Irreplaceable fluid, labeling gap Escalate to pathologist/supervisor for documented decision
Problem resolution means using written procedures, dual verification, and audit trails—not informal hallway agreements.
Never Re-Label Without a Policy-Approved Process
Re-labeling is a high-risk control. Acceptable pathways (examples—your SOP governs):
Collector still present with the patient and original labeled tube; identity re-verified with wristband; new label applied under observation; event documented.
Formal laboratory variance approved by supervisory authority for irreplaceable specimens with clinical team acknowledgment.
Aliquot labeling from a correctly labeled primary after accessioning—secondary containers inherit identity through controlled LIS labels, not sticky notes.
Unacceptable:
“The only patient on the unit with that test.”
Matching by bed number alone.
Copying a name from an unattached requisition found in the bag.
Using a leftover label from a printer batch.
If you did not verify identity at collection, you cannot safely create identity later.
Patient Safety Priority: How to Talk About Rejects
Clinical partners may pressure processing staff to “just run it.” Use a short, firm script:
“I can’t result this specimen because the identity doesn’t meet lab policy. We’ll need a recollect with two identifiers on the tube. I’ll document the rejection and help get the correct labels sent.”
Escalation path: MLA → lead/supervisor → laboratory medical director pathway for disputes. Never let hierarchy intimidation override labeling policy; accreditation and patient harm land on the laboratory that resulted the wrong patient’s sample.
Mini Checklist at Receipt
Two identifiers present and legible on the specimen ?
Identifiers match order/requisition/LIS?
Collection date/time/collector present when required?
Tube closed, unexpired, correct type for tests?
If any hard-fail → quarantine, reject code, notify, document.
If soft issue → follow written problem-resolution SOP only.
Key Takeaways
Labels live on the specimen , with two identifiers matching the order.
Unlabeled/mislabeled = reject ; do not process.
Opened or expired tubes fail integrity even when names match.
Re-label only via approved, documented process —patient safety outranks speed.